Loading...

Asymchem Laboratories (Tianjin) Co., Ltd.

6821.HKHKSE
HealthcareBiotechnology
HK$71.40
HK$0.70(0.99%)

Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK) Stock Overview

Explore Asymchem Laboratories (Tianjin) Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
-25.82%
25.82%
Profit Growth
HK$2.71
58.17%
EPS Growth
HK$2.71
57.03%
Operating Margin
19.22%
58.04%
ROE
5.93%
58.17%
Dividend Yield
0.00%
0.66%
Analyst Recommendations data is not available for 6821.HKAnalyst Recommendations details for 6821.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.

CEO

Dr. Hao Hong Ph.D.

Employees

9,595

Headquarters

No. 6 Dongting 3rd Street, Tianjin

Founded

2021

Frequently Asked Questions